RTTR

Ritter Pharmaceuticals (RTTR)

Ritter Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RTTR

<< 前へ 1 2 3 4 5 6 7 8 9 10 11 12 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2018/05/03	19 : 00	GlobeNewswire Inc.	Ritter Pharmaceuticals Selects Medpace as its Clinical Research Organization for Pivotal Phase 3 Clinical Trial of RP-G28 in ...	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/04/14	05 : 38	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/03/23	00 : 43	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/03/23	00 : 35	GlobeNewswire Inc.	Ritter Pharmaceuticals Announces 1-for-10 Reverse Stock Split	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/03/19	19 : 45	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/03/19	19 : 37	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/03/19	19 : 35	GlobeNewswire Inc.	Ritter Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/03/12	19 : 00	GlobeNewswire Inc.	Ritter Pharmaceuticals Reports Microbiome Data from Phase 2b Study of RP-G28 Promotes Beneficial Adaptation of the Gut Microb...	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/03/05	20 : 00	GlobeNewswire Inc.	Ritter Pharmaceuticals to Present at 30th Annual ROTH Conference on March 13	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/03/02	07 : 51	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/03/02	06 : 20	GlobeNewswire Inc.	Ritter Pharmaceuticals, Inc.’s Board Approves 1-for-10 Reverse Stock Split	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/02/20	19 : 30	GlobeNewswire Inc.	Ritter Pharmaceuticals Appoints Distinguished Gastroenterologist, William Chey, M.D., to Medical Advisory Board	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/02/15	05 : 28	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/02/14	06 : 39	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/01/29	23 : 00	GlobeNewswire Inc.	Ritter Pharmaceuticals Appoints Diane J. Plotkin as Vice President of Clinical Development, Ahead of the Launch of its Phase ...	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2018/01/10	04 : 31	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/12/21	07 : 19	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/12/01	20 : 21	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/12/01	20 : 16	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/11/29	23 : 30	GlobeNewswire Inc.	Ritter Pharmaceuticals Presents at the 10th Annual LD Micro Conference on December 5, 2017	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/11/29	04 : 49	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/11/07	20 : 07	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/11/03	05 : 52	GlobeNewswire Inc.	Ritter Pharmaceuticals Presents at the 5th Microbiome R&D Business Collaboration Forum / 2nd Annual Probiotic Congress	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/10/31	19 : 45	GlobeNewswire Inc.	Ritter Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/10/31	19 : 17	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/10/31	19 : 07	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/10/28	03 : 04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/10/28	02 : 59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/10/28	02 : 54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/10/28	02 : 53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc